Valuation
publishLooking for the best stocks based on fundamental valuation metrics? The Stocklytics Valuation Screener simplifies your search by ranking stocks in ascending order of price-to-earnings (PE) ratio, helping you identify undervalued opportunities at a glance.
| name | arrow_upwardPE Ratio | Price | $ Change | % Change | Market Cap | PEG (TTM) | P/S | P/B | P/CF | P/FCF | EV | EV/EBIT | EV/ EBITDA | EV/R | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
QMCOQuantum | - | $11.84 | -$0.88 | arrow_drop_down6.83% | $73.11M | - | 0.24 | 0.00 | - | - | 194.57M | -1.86 | -9.13 | 0.68 | |||
DERMJourney Medical | - | $6.94 | $0.13 | arrow_drop_up1.90% | $165.39M | - | 2.03 | 10.76 | - | - | 114.96M | -7.04 | 17.71 | 1.99 | |||
BNGOBioNano Genomics | - | $3.74 | -$0.04 | arrow_drop_down1.06% | $13.22M | - | 0.29 | 0.19 | - | - | 9.22M | - | -0.17 | 0.27 | |||
VERBVerb Technology Co | - | $6.45 | $0.18 | arrow_drop_up2.87% | $8.03M | - | 23.41 | 0.27 | - | - | 0.00 | - | -0.21 | 37.54 | |||
TPCTutor Perini | - | $35.85 | $0.83 | arrow_drop_up2.37% | $1.91B | 1.24 | 0.35 | 1.35 | 2.91 | 3.14 | 1.621B | - | 63.14 | 0.37 | |||
CFLTConfluent | - | $21.84 | -$0.08 | arrow_drop_down0.36% | $7.73B | 0.70 | 11.00 | 11.03 | 242.83 | 544.99 | 9.807B | - | -18.93 | 10.17 | |||
ITCIIntra-Cellular Therapies | - | $131.87 | -$0.02 | arrow_drop_down0.01% | $14.04B | 0.00 | 20.02 | 11.86 | - | - | 12.647B | - | -37.12 | 18.58 | |||
BPMCBlueprint Medicines | - | $101.25 | $0.87 | arrow_drop_up0.87% | $6.42B | 0.00 | 12.12 | 20.67 | - | - | 6.028B | - | 313.41 | 11.84 | |||
RVYLRyvyl | - | $0.61 | -$0.04 | arrow_drop_down6.76% | $5.87M | - | 0.12 | 1.20 | 0.22 | 0.23 | 25.05M | -0.58 | -6.08 | 0.39 | |||
BTGB2Gold | - | $3.35 | $0.05 | arrow_drop_up1.63% | $3.88B | 4.71 | 1.85 | 1.17 | 15.24 | - | 3.632B | 6.32 | 6.97 | 1.90 | |||
TWSTTwist Bioscience | - | $28.32 | $0.18 | arrow_drop_up0.63% | $1.80B | - | 7.01 | 5.07 | - | - | 2.127B | - | -35.26 | 6.44 | |||
ZYMEZymeworks | - | $11.47 | $0.01 | arrow_drop_up0.08% | $803.45M | 0.00 | 14.83 | 2.51 | - | - | 646.00M | -5.39 | 0.33 | 10.38 | |||
ACIUAC Immune SA | - | $1.66 | -$0.02 | arrow_drop_down1.47% | $157.64M | 0.00 | 6.13 | 1.72 | 2.05 | 2.06 | 79.32M | -3.62 | -0.76 | 1.74 | |||
SMSISmith Micro Software | - | $0.79 | -$0.00 | arrow_drop_down0.85% | $17.02M | 0.00 | 0.95 | 0.61 | - | - | 24.48M | -0.91 | 52.82 | 1.01 | |||
RELYRemitly Global | - | $22.38 | -$0.22 | arrow_drop_down0.99% | $4.65B | - | 3.80 | 7.23 | 24.05 | 25.14 | 4.462B | - | -33.69 | 3.53 | |||
QTWOQ2 Holdings | - | $86.89 | -$0.43 | arrow_drop_down0.49% | $5.62B | 8.93 | 7.61 | 10.24 | 37.62 | 41.08 | 5.402B | - | 125.95 | 7.75 | |||
 TGTXTG Therapeutics | - | $34.44 | $0.22 | arrow_drop_up0.64% | $5.33B | 0.00 | 17.68 | 24.40 | - | - | 4.601B | - | 790.34 | 17.37 | |||
ZETAZeta Global Holdings | - | $13.16 | -$0.06 | arrow_drop_down0.48% | $3.28B | 0.67 | 4.06 | 6.04 | 26.44 | 33.96 | 3.921B | - | -10.50 | 3.89 | |||
YMABY-mAbs Therapeutics | - | $4.26 | $0.04 | arrow_drop_up0.96% | $174.79M | - | 2.94 | 2.69 | - | - | 181.98M | -6.39 | -0.43 | 2.15 | |||
XBITXBiotech | - | $2.82 | $0.05 | arrow_drop_up1.76% | $90.85M | 0.00 | 12.23 | 0.56 | - | - | 0.00 | - | -1.60 | 24.05 |
Showing 981-1000 of 1046
Results per page:
Looking for the best stocks based on fundamental valuation metrics? The Stocklytics Valuation Screener simplifies your search by ranking stocks in ascending order of price-to-earnings (PE) ratio, helping you identify undervalued opportunities at a glance.
Our screener doesn’t stop at PE ratio. We dive deep into additional critical metrics that matter for smarter investments:
- PEG Ratio – Evaluate stocks with growth factored in for a more complete view.
- Price-to-Sales (P/S) Ratio – Identify stocks priced attractively relative to their revenue.
- Price-to-Book (P/B) Ratio – Find opportunities by comparing a company’s market value with its book value.
- Price-to-Cash Flow (P/CF) Ratio – Gauge how well a company generates cash compared to its stock price.
- Price-to-Free Cash Flow (P/FCF) Ratio – Discover companies generating healthy free cash flow, a key indicator of financial health.
We also provide enterprise valuation insights through metrics such as:
- Enterprise Value (EV) – A holistic view of a company’s total valuation.
- EV/EBIT – Focus on the core earnings without accounting distortions.
- EV/EBITDA – Evaluate profitability before depreciation and amortization.
- EV/Revenue – See how a company’s enterprise value stacks up against revenue.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools